[Senegal's experience with pacemakers re-use : about 161 patients at the Aristide Le Dantec university hospital center].

Autor: Tabane A; Universite Cheikh Anta Diop de Dakar, Sénégal; Service de cardiologie, Hôpital Aristide Le Dantec, Sénégal. Electronic address: aliounetabs@hotmail.com., Sarr SA; Universite Cheikh Anta Diop de Dakar, Sénégal; Service de cardiologie, Hôpital Aristide Le Dantec, Sénégal., Aw F; Universite Cheikh Anta Diop de Dakar, Sénégal; Service de cardiologie, Hôpital Aristide Le Dantec, Sénégal., Kane AD; Universite Gaston Berger de Saint Louis, Sénégal., Defaye P; Service de cardiologie, CHU Grenoble-Alpes, Sénégal.
Jazyk: francouzština
Zdroj: Annales de cardiologie et d'angeiologie [Ann Cardiol Angeiol (Paris)] 2024 Jun; Vol. 73 (3), pp. 101763. Date of Electronic Publication: 2024 May 08.
DOI: 10.1016/j.ancard.2024.101763
Abstrakt: Introduction: The reuse pacemakers is a beneficial technique for patients in countries with a low economic standard of living where health care is almost non-existent. We offered to share the experience of Senegal on the reconditioning of pacemakers.
Methodology: We conducted a retrospective study over a period from January 2015 to December 2020 including all patients who benefited from a reconditioned pacemaker for primary implantation or reimplantation. The criteria for reconditioning pacemakers are the absence of dysfunction or damage and a residual battery life of more than 5 years of the pacemaker. Refurbished pacemakers are acquired either from deceased families or from extraction centers. Sterilization is carried out using phenoxypropanol + benzalkonium chloride solution, 70% ethanol and ethylene oxide.
Results: We collected 161 patients during the study period, including 77 men (48%) and 84 women (52%), i.e. a M/F sex ratio of 0.94. The average age of the population was 65 years. Functional symptomatology was dominated by syncope in 54%. Electrocardiographically, 72% of patients were in complete atrioventricular block. A primary implantation was noted in 91.5% of patients. The vascular approach most used during implantation was cephalic in 49.5% of cases. In our series, we noted that 58% of patients had benefited from temporary stimulation before implantation. At implantation, single-chamber stimulation was used in 60% of patients and 46.5% of patients had programming in VVI mode. We had 5.5% major complications with 3% box infection occurring between 3 and 6 months post-implantation and 2.5% pacemaker syndrome. We noted 1 case of death linked to underlying heart disease.
Conclusion: Reconditioning of cardiac pacemakers is a safe and beneficial therapeutic strategy for patients. In Senegal, reconditioning has shown satisfactory results. In our countries this technique can be an alternative for certain patients.
Competing Interests: Déclaration de liens d'intérêts Les auteurs déclarent n'avoir aucun lien d'intérêts en rapport avec l’étude.
(Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: